Nina Reinart

Joseph Stelzmann Str. 26
Koeln, NW 50931, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression.

Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression.

Journal: British journal of haematology
Published: January 21, 2026

Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular source.

Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular source.

Journal: Journal of leukocyte biology
Published: May 15, 2025

CD74 is dispensable for development of chronic lymphocytic leukemia in Eµ-TCL1 transgenic mice.

CD74 is dispensable for development of chronic lymphocytic leukemia in Eµ-TCL1 transgenic mice.

Journal: Leukemia & lymphoma
Published: July 16, 2020

Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the Eµ-TCL1 Transgenic Mouse Model.

Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the Eµ-TCL1 Transgenic Mouse Model.

Journal: Cancers
Published: May 23, 2020

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.

Journal: Blood
Published: March 09, 2020

Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia.

Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia.

Journal: Leukemia
Published: May 15, 2016

LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.

LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia.

Journal: Cancer cell
Published: December 04, 2015

Impact of exercise on pro inflammatory cytokine levels and epigenetic modulations of tumor-competitive lymphocytes in Non-Hodgkin-Lymphoma patients-randomized controlled trial.

Impact of exercise on pro inflammatory cytokine levels and epigenetic modulations of tumor-competitive lymphocytes in Non-Hodgkin-Lymphoma patients-randomized controlled trial.

Journal: European journal of haematology
Published: June 01, 2014

Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine.

Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine.

Journal: Leukemia & lymphoma
Published: April 18, 2014

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.

Journal: Blood
Published: November 03, 2012

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.

Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.

Journal: Cancer
Published: September 24, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026